LILRA2, LILRA3, LILRA5, LILRB2, and LILRB3 are found at elevated levels in the sera and synovial fluid of RA patients, correlating with disease severity (25, 63, 72, 73, 87, 257). Here, LILRA2 is linked to rheumatoid arthritis.